271 related articles for article (PubMed ID: 2772324)
1. [Levels of blood theophylline in patients with acute bronchospasm].
Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E
Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324
[TBL] [Abstract][Full Text] [Related]
2. [Is routine monitoring of theophylline blood levels really effective?].
Atsmon J; Priel IE; Dolev E
Harefuah; 1995 Nov; 129(9):304-8, 368. PubMed ID: 8549976
[TBL] [Abstract][Full Text] [Related]
3. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
Salikova VV; Nonikov VE; Belousov IuB
Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
[TBL] [Abstract][Full Text] [Related]
4. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
Gandola L; Aiolfi S; Soccini F; Patrini G; Capellini G; Scartabellati A; Ghio L; Mauri F
Clin Ter; 1989 Dec; 131(5):293-7. PubMed ID: 2532583
[TBL] [Abstract][Full Text] [Related]
5. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
Andrasch R; Schmitz-Schumann M
Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
[TBL] [Abstract][Full Text] [Related]
6. [Theophylline overdoses on admission to a resuscitation unit].
Laaban JP; Dupeyron JP; Coignet MC; Bedos JP; Poirier T; Rochemaure J
Rev Mal Respir; 1987; 4(3):127-32. PubMed ID: 3616118
[TBL] [Abstract][Full Text] [Related]
7. [Prescription of Theostat 300 as a single evening dose].
Germouty J; Bida C; Moreau L
Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
[TBL] [Abstract][Full Text] [Related]
8. Post-mortem concentrations of salbutamol, terbutaline and theophylline in asthma patients.
Lindsjö M; Boman G; Lindström B; Strandberg K; Wiholm BE
Eur J Respir Dis; 1987 Jul; 71(1):2-9. PubMed ID: 3653302
[TBL] [Abstract][Full Text] [Related]
9. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation.
Dal Negro R; Turco P; Pomari C; Monici-Preti P
Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
Grassi V; Nicora M; Beretta A
Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic theophylline therapy in exercise-induced bronchospasm.
Bierman CW; Shapiro GG; Pierson WE; Dorsett CS
Pediatrics; 1977 Dec; 60(6):845-9. PubMed ID: 600596
[TBL] [Abstract][Full Text] [Related]
12. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
Gatto PG; Bruzzoni A; Valenti V
Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
[TBL] [Abstract][Full Text] [Related]
13. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
14. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401
[No Abstract] [Full Text] [Related]
15. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
Harder S; Staib AH; Stauder J
Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
[No Abstract] [Full Text] [Related]
16. Home monitoring of theophylline levels: a novel therapeutic approach.
Chandler MH; Clifton GD; Louis BA; Coons SJ; Foster TS; Phillips BA
Pharmacotherapy; 1990; 10(4):294-300. PubMed ID: 2388876
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
19. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
Wiesner B; Sehrt I; Iwainsky H
Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of plasma levels of 2 delayed-action theophyllines: Theostat 200 and Theodur 200, after a single evening dose].
Philip-Joet F; Bruguerolle B; Lagier F; Arnaud A
Rev Pneumol Clin; 1986; 42(6):279-83. PubMed ID: 3563255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
